| Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications A Wicki, D Witzigmann, V Balasubramanian, J Huwyler Journal of controlled release 200, 138-157, 2015 | 2010 | 2015 |
| Biocompatible functionalization of polymersome surfaces: a new approach to surface immobilization and cell targeting using polymersomes S Egli, MG Nussbaumer, V Balasubramanian, M Chami, N Bruns, ... Journal of the American Chemical Society 133 (12), 4476-4483, 2011 | 247 | 2011 |
| Aiding nature’s organelles: artificial peroxisomes play their role P Tanner, V Balasubramanian, CG Palivan Nano letters 13 (6), 2875-2883, 2013 | 187 | 2013 |
| Enzymatic cascade reactions inside polymeric nanocontainers: a means to combat oxidative stress P Tanner, O Onaca, V Balasubramanian, W Meier, CG Palivan Chemistry–A European Journal 17 (16), 4552-4560, 2011 | 159 | 2011 |
| Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications N Tahir, A Madni, V Balasubramanian, M Rehman, A Correia, PM Kashif, ... International journal of pharmaceutics 533 (1), 156-168, 2017 | 120 | 2017 |
| Drug‐loaded multifunctional nanoparticles targeted to the endocardial layer of the injured heart modulate hypertrophic Signaling MPA Ferreira, S Ranjan, S Kinnunen, A Correia, V Talman, E Mäkilä, ... Small 13 (33), 1701276, 2017 | 117 | 2017 |
| Multifaceted polymersome platforms: Spanning from self-assembly to drug delivery and protocells V Balasubramanian, B Herranz-Blanco, PV Almeida, J Hirvonen, ... Progress in Polymer Science 60, 51-85, 2016 | 113 | 2016 |
| SOD antioxidant nanoreactors: influence of block copolymer composition on the nanoreactor efficiency O Onaca, DW Hughes, V Balasubramanian, M Grzelakowski, W Meier, ... Macromolecular bioscience 10 (5), 531-538, 2010 | 90 | 2010 |
| Protein delivery: from conventional drug delivery carriers to polymeric nanoreactors V Balasubramanian, O Onaca, R Enea, DW Hughes, CG Palivan Expert opinion on drug delivery 7 (1), 63-78, 2010 | 89 | 2010 |
| Can polymeric vesicles that confine enzymatic reactions act as simplified organelles? P Tanner, S Egli, V Balasubramanian, O Onaca, CG Palivan, W Meier FEBS letters 585 (11), 1699-1706, 2011 | 85 | 2011 |
| Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy N Tahir, A Madni, A Correia, M Rehman, V Balasubramanian, MM Khan, ... International journal of nanomedicine, 4961-4974, 2019 | 84 | 2019 |
| Water-soluble Co (III) complexes of substituted phenanthrolines with cell selective anticancer activity S Jagadeesan, V Balasubramanian, P Baumann, M Neuburger, ... Inorganic chemistry 52 (21), 12535-12544, 2013 | 79 | 2013 |
| On‐chip self‐assembly of a smart hybrid nanocomposite for antitumoral applications B Herranz‐Blanco, D Liu, E Mäkilä, MA Shahbazi, E Ginestar, H Zhang, ... Advanced functional materials 25 (10), 1488-1497, 2015 | 75 | 2015 |
| Biomimetic Engineering Using Cancer Cell Membranes for Designing Compartmentalized Nanoreactors with Organelle-Like Functions. V Balasubramanian, A Correia, H Zhang, F Fontana, E Mäkilä, J Salonen, ... Advanced Materials (Deerfield Beach, Fla.) 29 (11), 2017 | 72 | 2017 |
| Polymersomes conjugated to 83-14 monoclonal antibodies: in vitro targeting of brain capillary endothelial cells LH Dieu, D Wu, CG Palivan, V Balasubramanian, J Huwyler European journal of pharmaceutics and biopharmaceutics 88 (2), 316-324, 2014 | 66 | 2014 |
| Light-responsive polymer nanoreactors: a source of reactive oxygen species on demand P Baumann, V Balasubramanian, O Onaca-Fischer, A Sienkiewicz, ... Nanoscale 5 (1), 217-224, 2013 | 61 | 2013 |
| A surprising system: polymeric nanoreactors containing a mimic with dual-enzyme activity V Balasubramanian, O Onaca, M Ezhevskaya, S Van Doorslaer, ... Soft Matter 7 (12), 5595-5603, 2011 | 60 | 2011 |
| Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction G Torrieri, F Fontana, P Figueiredo, Z Liu, MPA Ferreira, V Talman, ... Nanoscale 12 (4), 2350-2358, 2020 | 55 | 2020 |
| Quercetin‐based modified porous silicon nanoparticles for enhanced inhibition of doxorubicin‐resistant cancer cells Z Liu, V Balasubramanian, C Bhat, M Vahermo, E Mäkilä, M Kemell, ... Advanced healthcare materials 6 (3), 1601009, 2017 | 55 | 2017 |
| Angiopep2-functionalized polymersomes for targeted doxorubicin delivery to glioblastoma cells P Figueiredo, V Balasubramanian, MA Shahbazi, A Correia, D Wu, ... International journal of pharmaceutics 511 (2), 794-803, 2016 | 55 | 2016 |
